@martaealberto.bsky.social and @A_Frances_chem
now published in Inorg Chem Front! Photocatalytic arylterpyridine iridium(III) complexes trigger oncosis in 2D and 3D cancer cell models via NADH oxidation. pubs.rsc.org/en/content/a...
@martaealberto.bsky.social and @A_Frances_chem
now published in Inorg Chem Front! Photocatalytic arylterpyridine iridium(III) complexes trigger oncosis in 2D and 3D cancer cell models via NADH oxidation. pubs.rsc.org/en/content/a...
¿Cuándo se dará prioridad a lo que afecta a las personas?
@cigudosa-juancruz.bsky.social
@fpuinvestiga.bsky.social
👇
Más de 850 investigadores siguen sin contrato predoctoral por el retraso del Ministerio en resolver las ayudas
¿Cuándo se dará prioridad a lo que afecta a las personas?
@cigudosa-juancruz.bsky.social
@fpuinvestiga.bsky.social
👇
Más de 850 investigadores siguen sin contrato predoctoral por el retraso del Ministerio en resolver las ayudas
Organized by: Grupo Metalofármacos | PhD Program in Basic & Applied Chemistry Co-financed by: Master in Fine & Molecular Chemistry
👉 Don’t miss it! #UMU #Chemistry #Lecture
Organized by: Grupo Metalofármacos | PhD Program in Basic & Applied Chemistry Co-financed by: Master in Fine & Molecular Chemistry
👉 Don’t miss it! #UMU #Chemistry #Lecture
Join us at Univ. of Barcelona to apply for Juan de la Cierva–Formación 2025 🧬
💡 Light-activated drugs | PDT | Medicinal Chemistry
🎓 PhD obtained in 2024 or 2025 required
📅 Deadline: Nov 20, 2025
📩 vmarchan@ub.edu
| agandioso@ub.edu
Join us at Univ. of Barcelona to apply for Juan de la Cierva–Formación 2025 🧬
💡 Light-activated drugs | PDT | Medicinal Chemistry
🎓 PhD obtained in 2024 or 2025 required
📅 Deadline: Nov 20, 2025
📩 vmarchan@ub.edu
| agandioso@ub.edu
We explore Type I photoreactivity in cyclometalated Ir/Ru complexes. Proud to be corresponding author 💡 @joseruizlab.bsky.social @Marchanlab pubs.rsc.org/en/content/art…
We explore Type I photoreactivity in cyclometalated Ir/Ru complexes. Proud to be corresponding author 💡 @joseruizlab.bsky.social @Marchanlab pubs.rsc.org/en/content/art…
We explore Type I photoreactivity in cyclometalated Ir/Ru complexes. Proud to be corresponding author 💡 @joseruizlab.bsky.social @Marchanlab pubs.rsc.org/en/content/art…
We designed PlatinAI—a platinum complex active against cisplatin-resistant cells via a non-DNA-binding mechanism.
Link in comments 👇
#AI #Oncology #Metallodrugs
We designed PlatinAI—a platinum complex active against cisplatin-resistant cells via a non-DNA-binding mechanism.
Link in comments 👇
#AI #Oncology #Metallodrugs
A potential new first-line standard for this high-risk population.
Link in comments 👇
#mCRC #BRAF #ClinicalTrials #oncology
A potential new first-line standard for this high-risk population.
Link in comments 👇
#mCRC #BRAF #ClinicalTrials #oncology